The document discusses Clostridium difficile, an anaerobic bacterium that can cause pseudomembranous colitis and antibiotic-associated diarrhea. It produces toxins A and B which damage the colonic epithelium and cause inflammation. Risk factors include disruption of the normal gut microbiota by antibiotics and transmission from person to person. Clinical manifestations range from asymptomatic carriage to severe complications like toxic megacolon. Diagnosis involves stool testing and endoscopy may show pseudomembranes. Treatment involves stopping the inciting antibiotic and using metronidazole or vancomycin. Prevention focuses on hand hygiene and contact precautions when caring for infected patients.